Jaguar Animal Health (JAGX)
(Delayed Data from NSDQ)
$2.10 USD
-0.13 (-5.62%)
Updated Aug 7, 2025 04:00 PM ET
After-Market: $2.10 0.00 (0.00%) 6:36 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
JAGX 2.10 -0.13(-5.62%)
Will JAGX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for JAGX based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for JAGX
12 Health Care Stocks Moving In Monday's Pre-Market Session
Jaguar Health (JAGX) Advances in Canalevia-CA1 Study for Dogs | JAGX Stock News
Enrollment Initiated in Jaguar Health Study of its FDA Conditionally Approved Canalevia-CA1 ...
Jaguar Health initiates enrollment in study of Canalevia-CA1 drug for dogs
Coca Access and Benefit Sharing Agreement Authorized by Peru's National Institute of Agrarian ...